Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-02
2008-07-08
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S235200, C514S252110, C514S253040, C514S253090, C514S254020, C514S254090, C544S121000, C544S295000, C544S357000, C544S362000, C544S373000, C544S369000
Reexamination Certificate
active
07396830
ABSTRACT:
This disclosure provides compounds of Formula Ias described herein having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the disclosure is concerned with indole and azaindole piperazine diamide derivatives that possess unique antiviral activity. More particularly, the present disclosure relates to compounds useful for the treatment of HIV and AIDS.
REFERENCES:
Drug Evaluations by American Medical Association (6thEd.), pp. 1615-1627 (1986).
James Clint A.
Kadow John F.
Meanwell Nicholas A.
Pearce Bradley C.
Ruediger Edward H.
Bernhardt Emily
Bristol--Myers Squibb Company
LandOfFree
Piperazine amidines as antiviral agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazine amidines as antiviral agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine amidines as antiviral agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3968404